172 related articles for article (PubMed ID: 36975883)
1. Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Seeger J; Wöhrle J; Scheller B; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger R; On Behalf Of The Basket-Small Investigators
J Cardiovasc Dev Dis; 2023 Mar; 10(3):. PubMed ID: 36975883
[TBL] [Abstract][Full Text] [Related]
2. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
5. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
Mangner N; Farah A; Ohlow MA; Möbius-Winkler S; Weilenmann D; Wöhrle J; Linke A; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Scheller B; Jeger RV;
Circ Cardiovasc Interv; 2022 Feb; 15(2):e011325. PubMed ID: 35000455
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
Rubini Gimenez M; Scheller B; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Cattaneo M; Gilgen N; Kaiser C; Jeger RV
Clin Res Cardiol; 2023 Jul; ():. PubMed ID: 37495797
[TBL] [Abstract][Full Text] [Related]
7. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
[TBL] [Abstract][Full Text] [Related]
8. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
[TBL] [Abstract][Full Text] [Related]
9. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease.
Her AY; Shin ES; Kim S; Kim B; Kim TH; Sohn CB; Choi BJ; Park Y; Cho JR; Jeong YH
Cardiovasc Diabetol; 2023 May; 22(1):120. PubMed ID: 37210516
[TBL] [Abstract][Full Text] [Related]
10. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
Mahfoud F; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Kaiser C; Cattaneo M; Scheller B; Jeger RV
Clin Res Cardiol; 2022 Jul; 111(7):806-815. PubMed ID: 35220449
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial.
Farah A; Elgarhy M; Ohlow MA; Wohrle J; Mangner N; Möbius-Winkler S; Cattaneo M; Gilgen N; Scheller B; Jeger R
Postepy Kardiol Interwencyjnej; 2022 Jun; 18(2):122-130. PubMed ID: 36051841
[TBL] [Abstract][Full Text] [Related]
12. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease.
Megaly M; Buda K; Saad M; Tawadros M; Elbadawi A; Basir M; Abbott JD; Rinfret S; Alaswad K; Brilakis ES
Cardiovasc Revasc Med; 2022 Feb; 35():76-82. PubMed ID: 33858783
[TBL] [Abstract][Full Text] [Related]
13. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
[TBL] [Abstract][Full Text] [Related]
15. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions.
Her AY; Kim B; Ahn SH; Park Y; Cho JR; Jeong YH; Shin ES
Yonsei Med J; 2023 Jun; 64(6):359-365. PubMed ID: 37226562
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
[TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloon versus Drug-Eluting Stent in Patients with Small-Vessel Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
Wu X; Li L; He L
Cardiol Res Pract; 2021; 2021():1647635. PubMed ID: 33953973
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Drug-Coated Balloon Approaches for
Zhong PY; Ma Y; Shang YS; Niu Y; Bai N; Wang ZL
Front Cardiovasc Med; 2022; 9():899701. PubMed ID: 35800174
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Efficacy and Safety Between Drug-Coated Balloons Versus Drug-Eluting Stents in the Treatment of De Novo Coronary Lesions in Large Vessels: A Study-Level Meta-Analysis of Randomized Control Trials.
Sun B; Zhang XT; Chen RR
Cardiovasc Drugs Ther; 2023 Nov; ():. PubMed ID: 37999833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]